1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Petra Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors Serabelisib, Canagliflozin 300mg - Breast Cancer, Endometrial Cancer | Phase 1 / Phase 2 | Unknown | Petra Pharma | 60 | 2020-09-01 | 2020-05-21 |
Breast Neoplasms (1) · Colonic Neoplasms (1) · Endometrial Neoplasms (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1)
Canagliflozin (1) · serabelisib (1)
Albert Yu, MD (1)